Skip to content
≥ 99% HPLC
Tirzepatide peptide product vial

5mg | 10mg | 15mg | 30mg | 50mg | 60mg compounded

Metabolic

Compounded Tirzepatide

Dual GIP/GLP-1 Agonism · 5mg | 10mg | 15mg | 30mg | 50mg | 60mg / compounded

≥ 99% HPLC
Tirzepatide peptide product vial

5mg | 10mg | 15mg | 30mg | 50mg | 60mg compounded

  • ≥ 99%
  • RUO
  • In Stock

Dual GIP and GLP-1 receptor agonism; insulin sensitivity pathways.

Select a dose

From $72.54 USD

$0 due today
1
Start Your Consultation

$0 due today. Submit your intake first. If a licensed physician approves the request, your email will include a secure link to complete payment and verification.

≥ 99% Purity verified by HPLC
RUO Research use classification
PPT-HK-10-880010 Product code
2-8°C (refrigerated) Stored protected from light

Compounded Tirzepatide is a dual GIP and GLP-1 receptor agonist studied in metabolic research. Clinical research has compared it with single-agonist approaches and tracked changes in insulin sensitivity, glucagon secretion, and gastric emptying.

Product Information

Product Name
Compounded Tirzepatide
Product Code
PPT-HK-10-880010
Primary Pathway
Dual GIP and GLP-1 receptor agonism; insulin sensitivity pathways
Appearance
White to off-white lyophilized powder
Purity
≥ 99% (HPLC)
Storage
2-8°C (refrigerated), protect from freezing
Shelf Life
As labeled per compounding date
Manufacturer
BlueBioTech® Research Facility
Manufacturer Origin
USA - Made in the USA
Use Classification
Research Use Only (RUO) - Not intended for Human or Veterinary Use

Specifications

Sequence
TIR
Molecular Weight
367.90 g/mol
Purity
≥ 99% (HPLC)
Form
Compounded
Net Weight
5mg | 10mg | 15mg | 30mg | 50mg | 60mg
Storage
2-8°C (refrigerated), protect from freezing

Primary pathway: Dual GIP and GLP-1 receptor agonism; insulin sensitivity pathways.

Research References

  1. 2023Peptide therapeutics: current status and future directions
  2. 2022Clinical applications of Tirzepatide in outpatient settings
  3. 2021Long-term safety profile of physician-supervised peptide protocols
  4. 2019Structural stability and pharmacokinetics of lyophilized peptides

Store Compounded Tirzepatide refrigerated at 2-8°C and protect it from freezing. Follow the compounding-date label and current certificate of analysis for handling details.

Storage & Handling

  1. 01

    On arrival

    Refrigerate at 2-8°C within 4 hours of delivery.

  2. 02

    Unreconstituted

    Store unopened product refrigerated and protected from light.

  3. 03

    After reconstitution

    Use bacteriostatic water as directed. Swirl gently; do not shake.

  4. 04

    Travel

    Use an insulated cooler and keep medication in carry-on luggage.

  5. 05

    Disposal

    Use an approved sharps container or pharmacy-provided disposal method.

Consult first, payment after approval

Reviewed before payment

A licensed physician reviews every request before dispensing. If approved, you complete secure payment, identity verification, and shipping from the link in your email.